Anterix (NASDAQ:ATEX – Get Free Report) announced its quarterly earnings data on Wednesday. The company reported ($0.51) EPS for the quarter, missing the consensus estimate of ($0.24) by ($0.27), reports. Anterix had a negative net margin of 217.80% and a negative return on equity of 18.42%. The company had revenue of $1.26 million during the quarter, compared to analyst estimates of $1.52 million.
Anterix Stock Performance
NASDAQ:ATEX opened at $36.29 on Friday. The firm has a 50-day moving average price of $32.13 and a two-hundred day moving average price of $33.08. Anterix has a twelve month low of $27.20 and a twelve month high of $40.45.
Insider Buying and Selling at Anterix
In other Anterix news, CFO Timothy Gray sold 16,667 shares of the firm’s stock in a transaction dated Thursday, May 2nd. The shares were sold at an average price of $31.91, for a total transaction of $531,843.97. Following the completion of the transaction, the chief financial officer now directly owns 90,475 shares in the company, valued at approximately $2,887,057.25. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. 31.71% of the stock is currently owned by insiders.
Institutional Investors Weigh In On Anterix
About Anterix
Anterix Inc operates as a wireless communications company. The company focuses on commercializing its spectrum assets to enable the targeted utility and critical infrastructure customers to deploy private broadband networks and innovative broadband solutions. It holds licensed spectrum in the 900 MHz band with coverage throughout the United States, Alaska, Hawaii, and Puerto Rico.
Further Reading
- Five stocks we like better than Anterix
- EV Stocks and How to Profit from Them
- Albemarle Stock: Strong Fundamentals vs. Lithium Volatility
- High Dividend REITs: Are They an Ideal Way to Diversify?
- MongoDB Stock: Analysts Recommend Buying the Dip
- How to Use Stock Screeners to Find Stocks
- UniFirst Stock: Value-Building Sends a Signal to the Market
Receive News & Ratings for Anterix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Anterix and related companies with MarketBeat.com's FREE daily email newsletter.